Minuet 发表于 2025-3-26 21:54:10

http://reply.papertrans.cn/1/57/5681/5681-31.png

seroma 发表于 2025-3-27 04:25:21

Submitted on: 07 October 2022.
Revised on: 27 December 2022.
Accepted on: 16 February 2023.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

Medicaid 发表于 2025-3-27 07:12:08

http://reply.papertrans.cn/1/57/5681/5681-33.png

昆虫 发表于 2025-3-27 11:19:22

Submitted on: 07 October 2022.
Revised on: 18 December 2022.
Accepted on: 28 January 2023.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

受人支配 发表于 2025-3-27 16:30:57

Submitted on: 23 November 2004.
Revised on: 24 February 2005.
Accepted on: 09 April 2005.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

ASSET 发表于 2025-3-27 18:13:07

Submitted on: 17 January 2012.
Revised on: 30 March 2012.
Accepted on: 13 April 2012.

___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS
页: 1 2 3 [4]
查看完整版本: SCIE期刊CLINICAL NEUROPHARMACOLOGY 2024/2025影响因子:0.816 (CLIN NEUROPHARMACOL) (0362-5664). (CLINICAL NEUROLOGY)(临床神经病学)Sci